lithium has been researched along with Diseases, Metabolic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Gaal, LF; Verhaegen, AA | 1 |
| McIntyre, RS | 1 |
| Clark, WF; Garg, AX; Garofeanu, CG; Henson, G; Rosas-Arellano, MP; Weir, M | 1 |
| Müller-Oerlinghausen, B; Pietzcker, A | 1 |
| Larson, EW; Richelson, E | 1 |
4 review(s) available for lithium and Diseases, Metabolic
| Article | Year |
|---|---|
Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update.
Topics: Adrenal Cortex Hormones; Animals; Anti-Retroviral Agents; Antidepressive Agents; Antipsychotic Agents; Body Fat Distribution; Body Weight; Cardiovascular Diseases; Diabetes Mellitus; HIV Infections; Humans; Insulin Resistance; Lithium; Metabolic Diseases; Obesity; Weight Gain | 2021 |
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Metabolic Diseases; Obesity; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2010 |
Causes of reversible nephrogenic diabetes insipidus: a systematic review.
Topics: Anti-Infective Agents; Antineoplastic Agents; Cohort Studies; Cross-Sectional Studies; Diabetes Insipidus, Nephrogenic; Humans; Hypercalcemia; Kidney; Lithium; Metabolic Diseases; Risk Factors | 2005 |
Organic causes of mania.
Topics: Adolescent; Adult; Bipolar Disorder; Brain Diseases; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Lithium; Lithium Carbonate; Metabolic Diseases | 1988 |
1 other study(ies) available for lithium and Diseases, Metabolic
| Article | Year |
|---|---|
The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research tool.
Topics: Adult; Aged; Antipsychotic Agents; Blood Glucose; Clinical Trials as Topic; Depressive Disorder; Humans; Kidney Diseases; Lithium; Metabolic Diseases; Middle Aged; Outpatient Clinics, Hospital; Patient Compliance; Perazine; Schizophrenia | 1984 |